Market Outlook:
The global pharmaceutical excipients market is projected to grow from USD 11.03 billion in 2025 to USD 14.86 billion by 2030, registering a CAGR of 6.1%. Growth is driven by rising demand for generic and innovative pharmaceutical products, increased adoption of novel excipients, and a strong shift toward patient-centric and advanced drug formulations.
Key Highlights:
– North America accounted for the largest share (29.8%) in 2024.
– Organic chemicals dominated the product segment with 86.1% share.
– Topical formulations expected to grow at the highest CAGR (7.6%) through 2030.
– Fillers & diluents formed the largest functionality segment in 2024.
– Stabilizers led functionality applications and are expected to maintain dominance.
Leading players: International Flavors & Fragrances Inc., ADM, Roquette Frères (Star players).
Notable SMEs: Innophos, Meggle GmbH & Co. KG, Fuji Chemical Industries.
Market Drivers, Restraints & Opportunities
Drivers:
– Rising demand for generics and diverse pharmaceutical formulations
– Increasing R&D investment in developing novel and advanced excipients
Restraints:
– Complex global regulatory frameworks
– High costs associated with excipient development and manufacturing
Opportunities:
– Growing interest in multifunctional, high-performance excipients
– Technological innovations including nanotechnology-enabled delivery systems
Challenges:
Persistent concerns around excipient safety and quality
Limited availability and fluctuating cost of some raw materials
Industry & Formulation Trends
Key trends influencing drug manufacturers and healthcare providers include:
– Shift toward patient-centric, controlled-release, and taste-masked formulations
– Growing adoption of biologics and advanced drug-delivery systems
– Increased focus on enhancing drug stability, solubility, and bioavailability
– Rising demand for natural, sustainable, and clean-label excipients
These trends create a strong need for customizable and multifunctional excipient solutions.
Download PDF Brochure – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=956
Commercial Applications
– Sustained-release tablets: Improve bioavailability and patient adherence
– BASF film-coating excipients: Enhance stability and mask unpleasant tastes
– Evonik lipid-based excipients: Support targeted delivery and nanomedicine applications
Regional Spotlight: Asia Pacific
APAC is projected to be the fastest-growing region through 2030, supported by:
– Rising generic drug consumption
– Expansion of pharmaceutical manufacturing capacities
– Growing R&D investments and supportive government initiatives
– Increasing utilization of functional and multifunctional excipients across formulations
Market Ecosystem Includes:
– Raw material suppliers: e.g., Dow Chemicals, Ashland
– Excipient manufacturers: e.g., BASF, Gattefossé
– End users: Global pharmaceutical companies such as Pfizer and Novartis
Close integration of suppliers, manufacturers, and pharma companies is central to driving innovation and regulatory compliance.
Recent Developments:
– Apr 2025: Kerry partnered with LBB Specialties for pharmaceutical lactose distribution in the US
– Feb 2025: IFF announced expansion of its Iowa facility to support global growth
– May 2024: Ashland launched Antaron soja glyceride, a biodegradable film for natural care and cosmetic applications.
